Nishimura M, Nakanishi T, Yasui A, Tsuji Y, Kunishige H, Hirabayashi M, Takahashi H, Yoshimura M
Department of Clinical Laboratory and Medicine, Kyoto Prefectural University of Medicine, Japan.
Am J Kidney Dis. 1992 Feb;19(2):149-55. doi: 10.1016/s0272-6386(12)70124-5.
We investigated the occurrence of arrhythmias during maintenance acetate hemodialysis (HD) using a 24-hour continuous electrocardiogram recording system. Three of 22 patients showed augmented increases in both ventricular premature beats and supraventricular premature beats during HD. When we changed the dialysate from one with a Ca2+ concentration of 1.75 mmol/L (3.5 mEq/L), to one with a Ca2+ concentration of 1.25 mmol/L (2.5 mEq/L), the elevation of serum Ca2+ concentration during HD was abolished and the increases in both ventricular premature beats and supraventricular premature beats were significantly decreased. The elevation of serum Ca2+ concentration during HD might induce either extracellular or intracellular increase in Ca2+ concentration in the heart and elicit either reentry- or triggered-activity types of arrhythmias during HD. The present results indicate that the dialysate with a lower Ca2+ concentration is advisable to use in patients with underlying cardiac diseases.
我们使用24小时连续心电图记录系统,对维持性醋酸盐血液透析(HD)期间心律失常的发生情况进行了调查。22例患者中有3例在HD期间室性早搏和室上性早搏均显著增加。当我们将透析液中Ca2+浓度从1.75 mmol/L(3.5 mEq/L)改为1.25 mmol/L(2.5 mEq/L)时,HD期间血清Ca2+浓度的升高被消除,室性早搏和室上性早搏的增加均显著减少。HD期间血清Ca2+浓度的升高可能会导致心脏细胞外或细胞内Ca2+浓度增加,并在HD期间引发折返或触发活动型心律失常。目前的结果表明,对于有潜在心脏疾病的患者,建议使用Ca2+浓度较低的透析液。